EU Regulators Told To ‘Normalize’ Decentralized Clinical Trials

 
• By Vibha Sharma

EU drug regulators have received some candid responses from trial sponsors and other stakeholders on the aspects that should be urgently addressed in the next iteration of their guidance on decentralized clinical trials.

Digital Clinical Trial
EU DCT Recommendation Paper Places Additional Obligations On Study Sponsors • Source: Shutterstock/Alfa Photo

More from Europe

More from Geography